Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts
Woolaver, R. A., Wang, X., Krinsky, A. L., Waschke, B. C., Chen, S., Popolizio, V., Nicklawsky, A. G., Gao, D., Chen, Z., Jimeno, A., Wang, X. J., & Wang, J. H. (2021). Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts. Journal for immunotherapy of cancer, 9(1), e001615. https://doi.org/10.1136/jitc-2020-001615